Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Houlihan Lokey (HLI) EBITDA (2016 - 2025)

Houlihan Lokey has reported EBITDA over the past 12 years, most recently at $116.1 million for Q4 2025.

  • For Q4 2025, EBITDA rose 146.22% year-over-year to $116.1 million; the TTM value through Dec 2025 reached $504.7 million, up 54.49%, while the annual FY2025 figure was $403.0 million, 45.76% up from the prior year.
  • EBITDA for Q4 2025 was $116.1 million at Houlihan Lokey, up from $97.7 million in the prior quarter.
  • Over five years, EBITDA peaked at $171.9 million in Q4 2021 and troughed at $32.2 million in Q3 2022.
  • A 5-year average of $89.4 million and a median of $87.4 million in 2021 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: plummeted 69.89% in 2022 and later surged 164.93% in 2024.
  • Year by year, EBITDA stood at $171.9 million in 2021, then tumbled by 49.24% to $87.3 million in 2022, then rose by 10.45% to $96.4 million in 2023, then tumbled by 51.07% to $47.2 million in 2024, then skyrocketed by 146.22% to $116.1 million in 2025.
  • Business Quant data shows EBITDA for HLI at $116.1 million in Q4 2025, $97.7 million in Q3 2025, and $145.9 million in Q2 2025.